AxoGen Debt to Equity Ratio 2010-2025 | AXGN
Current and historical debt to equity ratio values for AxoGen (AXGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AxoGen debt/equity for the three months ending March 31, 2025 was 0.63.
| AxoGen Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.09B | $0.11B | 0.86 |
| 2024-12-31 | $0.10B | $0.10B | 0.96 |
| 2024-09-30 | $0.09B | $0.10B | 0.93 |
| 2024-06-30 | $0.09B | $0.10B | 0.97 |
| 2024-03-31 | $0.09B | $0.09B | 1.00 |
| 2023-12-31 | $0.10B | $0.10B | 1.06 |
| 2023-09-30 | $0.10B | $0.10B | 0.99 |
| 2023-06-30 | $0.09B | $0.10B | 0.97 |
| 2023-03-31 | $0.09B | $0.10B | 0.94 |
| 2022-12-31 | $0.09B | $0.10B | 0.94 |
| 2022-09-30 | $0.09B | $0.10B | 0.93 |
| 2022-06-30 | $0.09B | $0.10B | 0.93 |
| 2022-03-31 | $0.09B | $0.10B | 0.91 |
| 2021-12-31 | $0.10B | $0.11B | 0.85 |
| 2021-09-30 | $0.10B | $0.12B | 0.82 |
| 2021-06-30 | $0.09B | $0.12B | 0.77 |
| 2021-03-31 | $0.08B | $0.12B | 0.65 |
| 2020-12-31 | $0.08B | $0.12B | 0.64 |
| 2020-09-30 | $0.07B | $0.12B | 0.59 |
| 2020-06-30 | $0.05B | $0.12B | 0.42 |
| 2020-03-31 | $0.02B | $0.12B | 0.17 |
| 2019-12-31 | $0.02B | $0.13B | 0.17 |
| 2019-09-30 | $0.02B | $0.14B | 0.14 |
| 2019-06-30 | $0.02B | $0.14B | 0.14 |
| 2019-03-31 | $0.02B | $0.14B | 0.14 |
| 2018-12-31 | $0.01B | $0.15B | 0.09 |
| 2018-09-30 | $0.01B | $0.15B | 0.08 |
| 2018-06-30 | $0.01B | $0.15B | 0.07 |
| 2018-03-31 | $0.03B | $0.02B | 1.54 |
| 2017-12-31 | $0.03B | $0.03B | 1.34 |
| 2017-09-30 | $0.03B | $0.01B | 3.00 |
| 2017-06-30 | $0.03B | $0.01B | 2.78 |
| 2017-03-31 | $0.03B | $0.01B | 2.57 |
| 2016-12-31 | $0.03B | $0.02B | 2.11 |
| 2016-09-30 | $0.03B | $0.00B | 26.88 |
| 2016-06-30 | $0.03B | $0.00B | 10.37 |
| 2016-03-31 | $0.03B | $0.01B | 5.92 |
| 2015-12-31 | $0.03B | $0.01B | 3.48 |
| 2015-09-30 | $0.03B | $0.01B | 2.66 |
| 2015-06-30 | $0.03B | $0.00B | -8.20 |
| 2015-03-31 | $0.03B | $0.00B | -42.35 |
| 2014-12-31 | $0.03B | $-0.01B | -2.46 |
| 2014-09-30 | $0.03B | $-0.01B | -2.97 |
| 2014-06-30 | $0.03B | $-0.01B | -4.12 |
| 2014-03-31 | $0.03B | $0.00B | -7.65 |
| 2013-12-31 | $0.03B | $0.00B | 201.67 |
| 2013-09-30 | $0.03B | $0.00B | 6.23 |
| 2013-06-30 | $0.03B | $-0.01B | -2.69 |
| 2013-03-31 | $0.02B | $-0.01B | -3.97 |
| 2012-12-31 | $0.02B | $0.00B | -8.15 |
| 2012-09-30 | $0.01B | $0.00B | 7.05 |
| 2012-06-30 | $0.01B | $0.00B | 2.01 |
| 2012-03-31 | $0.01B | $0.00B | 1.54 |
| 2011-12-31 | $0.01B | $0.01B | 1.06 |
| 2011-09-30 | $0.01B | $0.01B | 0.82 |
| 2011-06-30 | $0.00B | $0.01B | 0.05 |
| 2011-03-31 | $0.00B | $0.01B | 0.02 |
| 2010-12-31 | $0.02B | $-0.01B | -1.55 |
| 2010-09-30 | $0.00B | $0.01B | 0.01 |
| 2010-06-30 | $0.00B | $0.01B | 0.01 |
| 2010-03-31 | $0.00B | $0.01B | 0.04 |
| 2009-12-31 | $0.01B | $0.01B | 0.52 |
| 2009-09-30 | $0.00B | $0.00B | 1.44 |
| 2009-06-30 | $0.00B | $0.00B | 1.31 |
| 2009-03-31 | $0.00B | $0.00B | 1.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.498B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.503B | 85.19 |
| Thermo Fisher Scientific (TMO) | United States | $151.179B | 18.29 |
| Edwards Lifesciences (EW) | United States | $43.872B | 28.76 |
| Alcon (ALC) | Switzerland | $42.488B | 28.71 |
| IDEXX Laboratories (IDXX) | United States | $40.599B | 46.66 |
| DexCom (DXCM) | United States | $33.262B | 51.41 |
| STERIS (STE) | Ireland | $23.954B | 26.41 |
| IQVIA Holdings (IQV) | United States | $23.881B | 13.38 |
| Mettler-Toledo (MTD) | United States | $23.609B | 28.08 |
| Waters (WAT) | United States | $20.737B | 29.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.307B | 0.00 |
| Hologic (HOLX) | United States | $12.141B | 13.19 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $10.330B | 81.08 |
| Masimo (MASI) | United States | $8.128B | 29.98 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Glaukos (GKOS) | United States | $5.553B | 0.00 |
| Teleflex (TFX) | United States | $5.344B | 8.82 |
| TransMedics (TMDX) | United States | $4.172B | 90.69 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.146B | 30.11 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.990B | 17.89 |
| Alphatec Holdings (ATEC) | United States | $1.824B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.375B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.84 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.672B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.73 |
| RxSight (RXST) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.603B | 13.19 |
| NeuroPace (NPCE) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.98 |
| Delcath Systems (DCTH) | United States | $0.562B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.33 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.283B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| 908 Devices (MASS) | United States | $0.170B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.80 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 16.45 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.75 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |